1. Home
  2. TNK vs MNKD Comparison

TNK vs MNKD Comparison

Compare TNK & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Tankers Ltd.

TNK

Teekay Tankers Ltd.

HOLD

Current Price

$70.45

Market Cap

2.4B

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$5.67

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNK
MNKD
Founded
2007
1991
Country
Bermuda
United States
Employees
2000
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
1.8B
IPO Year
2007
2004

Fundamental Metrics

Financial Performance
Metric
TNK
MNKD
Price
$70.45
$5.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$65.00
$10.08
AVG Volume (30 Days)
368.3K
3.8M
Earning Date
02-18-2026
03-02-2026
Dividend Yield
2.83%
N/A
EPS Growth
N/A
23.47
EPS
9.01
0.10
Revenue
$951,879,000.00
$313,787,000.00
Revenue This Year
N/A
$21.29
Revenue Next Year
N/A
$25.53
P/E Ratio
$7.83
$57.82
Revenue Growth
N/A
17.43
52 Week Low
$33.35
$3.38
52 Week High
$70.75
$6.51

Technical Indicators

Market Signals
Indicator
TNK
MNKD
Relative Strength Index (RSI) 72.96 47.64
Support Level $62.31 $5.54
Resistance Level $70.09 $6.05
Average True Range (ATR) 2.05 0.29
MACD 0.31 -0.02
Stochastic Oscillator 86.61 25.88

Price Performance

Historical Comparison
TNK
MNKD

About TNK Teekay Tankers Ltd.

Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: